The FDA approved two zanidatamab-hrii-based regimens as first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma. Zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) received approval in combination with fluoropyrimidine- and platinum-containing…
What does Moderna's melanoma treatment mean for cancer research? We asked 2 local experts WBUR
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk prostate cancer indicate that SBRT improved bowel health-related quality of life…
Первая персональная мРНК-вакцина от меланомы успешно прошла клинические испытания Techinsider.ru
Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma. There is a great clinical need for new therapies for childhood osteosarcoma, for which there are very few effective…
Researchers from the University of Turku in Finland and Gustave Roussy Institute in France have discovered a molecular mechanism that regulates whether cells in an aggressive colorectal cancer are conventional or inverted as they spread in the body. The discovery can help identify patients at elevated risk of the…
Top 10 Cancer Research Grants Open to Researchers Worldwide Oncodaily
AHN teams up with START Center to expand early-phase oncology research in western Pennsylvania The Business Journals
Decoding Tumors: Inside the Spatial Revolution in Cancer Research Pfizer
New ’tissue-free’ blood test could detect breast cancer recurrence months before scans Oncology Central
The immune system possesses legions of T cells that, if primed, could hunt down and destroy tumors. Now, a UC San Francisco team has invented a way to do this by combining immune cells grown in the lab with samples from a patient's tumor. Like giving a scent to a hound dog, it shows the immune system how to go after…
Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney stones. Now researchers have developed an artificial intelligence system that can identify bladder cancer patients up to five years before their official diagnosis, potentially revolutionizing…